UK Medtechs Look Beyond Brexit To Long-Term Life-Science Strategy
Executive Summary
The UK medtech industry is looking past Brexit to a time when the government's new Life Science Strategy has gone live. It also seeks better access to the NHS for medtech companies developing and launching innovations as the UK makes its own way in the world as a former EU member state.
You may also be interested in...
UK Device, IVD Sector Cheered By New Funding Pledge For Accelerated Access Program
UK Government health minister James O'Shaughnessy has delighted local medtech innovators with the promise of a package of funding under the Accelerated Access Review (AAR).
Brexit Podcast: Next Steps For The UK Medtech Industry
Free: In Vivo's Ashley Yeo talks to Association of British Healthcare Industries' Nishan Sunthares and Richard Phillips about the subject that will dominate the thoughts, behavior and business of medical technology companies in the UK for many years to come.
Brexit Podcast: Next Steps For The UK Medtech Industry
Free: Medtech Insight's Ashley Yeo talks to Association of British Healthcare Industries' Nishan Sunthares and Richard Phillips about the subject that will dominate the thoughts, behavior and business of medical technology companies in the UK for many years to come.